Policy Case for Pharmacist Prescribing of Opioid Use Disorder Medications
This commentary argues that expanding pharmacist scope of practice to initiate and prescribe medications for opioid use disorder could close persistent access gaps in rural and underserved communities and support family preservation.
★ Editor's Pickbuprenorphinemethadoneextended-release naltrexonemedications for opioid use disorderMOUDpharmacist prescribingscope of practiceopioid use disorderaddiction medicinepolicy commentaryrural healthMAT ActTitle IV-Echild welfareBehavioral Health / Addiction Medicine
Background Information
Pharmacists prescribing for opioid use disorder could bridge access gaps in rural areas.
Access to medications for opioid use disorder is limited, especially in rural areas due to prescriber shortages and regulatory barriers. States could improve access by allowing pharmacists to initiate or prescribe these medications, supporting timely treatment and continuity of care. This change could expand the treatment workforce and improve care, especially in underserved areas, by leveraging pharmacists' accessibility. Authorizing pharmacists to prescribe medications for opioid use disorder could improve access and outcomes in underserved communities.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Adams AJ
Citation:Adams AJ Expanding access to medications for opioid use disorder through pharmacist scope-of-practice flexibility. Journal of the American Pharmacists Association : JAPhA. 2026:103522. doi:10.1016/j.japh.2026.103522